SECURITIES AND EXCHANGE COMMISSION |
|
FORM 8-K |
|
|
________________ |
|
Alpharma Inc. |
||
(Exact name of registrant as specified in its charter) |
||
Delaware (State or other jurisdiction of incorporation) |
1-8593 (Commission File Number) |
22-2095212 (IRS Employer Identification) |
One Executive Drive, Fort Lee, New Jersey 07024 |
Registrant's telephone number, including area code |
Not Applicable |
______________________________________________ |
last report) |
Item 1.01 Entry Into A Material Definitive Agreement
On April 19, 2005 the Compensation Committee of the Board of Directors (the "Committee') of the Registrant took the following actions:
Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
On April 19, 2005, Ms. Wiik informed the Committee that, consistent with the terms of her employment contract (filed as Exhibit 10.12 to the Registrant's Annual Report on Form 10-K for the year ended December 31, 2000), it was her desire to retire as the Registrant's President and Chief Executive Officer (but not as Vice Chairman or a member of the Board of Directors) on or about December 31, 2005. The Committee and Ms. Wiik agreed that the exact date of her retirement, and any other terms and conditions related to this action, would be subject to further discussions and the timing of the process to identify and elect her successor
ALPHARMA INC. |
|
By: /s/ Robert F. Wrobel |
|
Robert F. Wrobel |
Date: April 22, 2005